BioFinlandin jäsen
Herantis Pharma Plc
Yrityksen nimi
Herantis Pharma Plc
Osoite
Bertel Jungin aukio 1, FI-02600 Espoo
Puhelin
+358 9 222 1195
Työntekijät
10-49
Perustettu
2008
Yhteyshenkilö
antti.vuolanto at herantis.com
toimitusjohtaja
Antti Vuolanto
Verkkosivusto
Pääluokat
Drug Discovery and Development / Drug Delivery, Pharmaceutical
Viimeksi päivitetty
5 February 2019
Yrityksen profiili
Herantis Pharma Plc is an innovative drug development company focused on regenerative medicine and unmet clinical needs. Our clinical stage assets CDNF and Lymfactin® are based on globally leading scientific research in their fields. They both aim at breakthrough in the treatment of severe diseases: CDNF in neurodegenerative diseases such as Parkinson’s disease; and Lymfactin® in breast cancer associated lymphedema with potential also in other lymphedemas. The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.